The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

The direct impact of companies’ physical assets on the environment can be estimated from global maps of ecosystem services and biodiversity to understand companies’ nature-related risks and ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

A collaboration to enhance the readiness of healthcare clusters in the Kingdom in their transformation into newly-formed ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Drug coupon aggregator GoodRx and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to ...

Q3 2024 Earnings Call Transcript November 1, 2024 BrightSpring Health Services, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.04146 EPS, expectations were $0.17. Operator: ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business. Cigna ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.